Literature DB >> 2506531

A novel germ-line JK transcript starting immediately upstream of JK1.

L Leclercq1, P Butkeraitis, M Reth.   

Abstract

Germ-line transcripts of the immunoglobulin (Ig) and T cell receptor loci are thought to be involved in the control of V gene rearrangement by rendering these loci accessible to the recombinases. We have analyzed the transcriptional activity of germ-line K alleles in two bone marrow-derived Abelson-murine leukemia virus transformed pre-B cells: 300-19, a null cell line, and P8 a mu-producing line. We found a novel germ-line JK transcript starting immediately upstream of JK1 and spliced to CK. The potential role of this transcript in the opening of the Ig K locus as well as in the ordered usage of JK segments is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506531      PMCID: PMC318414          DOI: 10.1093/nar/17.17.6809

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  B lymphocyte-specific protein binding near an immunoglobulin kappa-chain gene J segment.

Authors:  D Weaver; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  Transcription of the unrearranged mouse C kappa locus: sequence of the initiation region and comparison of activity with a rearranged V kappa-C kappa gene.

Authors:  B G Van Ness; M Weigert; C Coleclough; E L Mather; D E Kelley; R P Perry
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  Accurate 5' splice-site selection in mouse kappa immunoglobulin light chain premessenger RNAs is not cell-type-specific.

Authors:  D H Kedes; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

7.  Structure of a nuclease-sensitive region inside the immunoglobin kappa gene: evidence for a role in gene regulation.

Authors:  T G Parslow; D K Granner
Journal:  Nucleic Acids Res       Date:  1983-07-25       Impact factor: 16.971

8.  Lipopolysaccharide-induced transcription of the kappa immunoglobulin locus occurs on both alleles and is independent of methylation status.

Authors:  K J Nelson; E L Mather; R P Perry
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

9.  Different joining region J elements of the murine kappa immunoglobulin light chain locus are used at markedly different frequencies.

Authors:  D L Wood; C Coleclough
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.

Authors:  M Schwab; K Alitalo; H E Varmus; J M Bishop; D George
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

View more
  11 in total

1.  Initiation and processing of two kappa immunoglobulin germ line transcripts in mouse B cells.

Authors:  D J Martin; B G van Ness
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

2.  Biallelic, ubiquitous transcription from the distal germline Ig{kappa} locus promoter during B cell development.

Authors:  Rupesh H Amin; Dragana Cado; Hector Nolla; Dan Huang; Susan A Shinton; Yan Zhou; Richard R Hardy; Mark S Schlissel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

3.  mRNA transcripts initiating within the human immunoglobulin mu heavy chain enhancer region contain a non-translatable exon and are extremely heterogeneous at the 5' end.

Authors:  G A Neale; G R Kitchingman
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

4.  Stimulation of kappa light-chain gene rearrangement by the immunoglobulin mu heavy chain in a pre-B-cell line.

Authors:  A M Shapiro; M S Schlissel; D Baltimore; A L DeFranco
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

5.  Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.

Authors:  A Strasser; A G Elefanty; A W Harris; S Cory
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

6.  A reappraisal of evidence for probabilistic models of allelic exclusion.

Authors:  Benjamin Taylor; Bradley S Cobb; Ludovica Bruno; Zoe Webster; Amanda G Fisher; Matthias Merkenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

7.  Molecular requirements for the mu-induced light chain gene rearrangement in pre-B cells.

Authors:  A Iglesias; M Kopf; G S Williams; B Bühler; G Köhler
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

8.  A surrogate 15 kDa JC kappa protein is expressed in combination with mu heavy chain by human B cell precursors.

Authors:  V Francés; D Pandrau-Garcia; C Guret; S Ho; Z Wang; V Duvert; S Saeland; H Martinez-Valdez
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

9.  Two new proteins preferentially associated with membrane immunoglobulin D.

Authors:  K M Kim; T Adachi; P J Nielsen; M Terashima; M C Lamers; G Köhler; M Reth
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

10.  The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein.

Authors:  M Terashima; K M Kim; T Adachi; P J Nielsen; M Reth; G Köhler; M C Lamers
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.